160 related articles for article (PubMed ID: 30762901)
1. Algorithms for ascertaining keratinocyte carcinomas using health insurance claims and prescription records.
Zhang T; Lee TK; Lui H; Kunimoto B; Han C; Zhou Y; Kalia S
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):e275-e276. PubMed ID: 30762901
[No Abstract] [Full Text] [Related]
2. Application of Recursive Partitioning to Derive and Validate a Claims-Based Algorithm for Identifying Keratinocyte Carcinoma (Nonmelanoma Skin Cancer).
Chan AW; Fung K; Tran JM; Kitchen J; Austin PC; Weinstock MA; Rochon PA
JAMA Dermatol; 2016 Oct; 152(10):1122-1127. PubMed ID: 27533718
[TBL] [Abstract][Full Text] [Related]
3. Trends in Non-Melanoma Skin Cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma) in Canada: A Descriptive Analysis of Available Data.
Abbas M; Kalia S
J Cutan Med Surg; 2016; 20(2):166-75. PubMed ID: 26458408
[TBL] [Abstract][Full Text] [Related]
4. A Model to Predict the Risk of Keratinocyte Carcinomas.
Whiteman DC; Thompson BS; Thrift AP; Hughes MC; Muranushi C; Neale RE; Green AC; Olsen CM;
J Invest Dermatol; 2016 Jun; 136(6):1247-1254. PubMed ID: 26908057
[TBL] [Abstract][Full Text] [Related]
5. Challenges in identifying predictors of subsequent keratinocyte carcinoma development: an institutional cohort analysis.
Thomas S; Taylor M; Sharma D; Plampton K; High R; Wysong A; Sutton A
Arch Dermatol Res; 2024 Jun; 316(7):410. PubMed ID: 38878204
[No Abstract] [Full Text] [Related]
6. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
7. Anatomic Locations of Procedurally Treated Keratinocyte Carcinomas in the US Medicare Population.
Navsaria LJ; Li Y; Tripathy S; Cox ML; Hinkston CL; Margolis DJ; Wehner MR
JAMA Dermatol; 2023 Jun; 159(6):643-647. PubMed ID: 37074701
[TBL] [Abstract][Full Text] [Related]
8. Incidence and mortality rates of keratinocyte carcinoma from 1998-2017: a population-based study of sex differences in Ontario, Canada.
Tang E; Fung K; Chan AW
CMAJ; 2021 Oct; 193(39):E1516-E1524. PubMed ID: 34607845
[TBL] [Abstract][Full Text] [Related]
9. Interrater reliability for histopathologic diagnosis of keratinocyte carcinomas.
Leader NF; Means AD; Robinson-Bostom L; Telang GH; Wilkel CS; Weinstock MA;
J Am Acad Dermatol; 2018 Jan; 78(1):185-187. PubMed ID: 29241779
[No Abstract] [Full Text] [Related]
10. The incidence and multiplicity rates of keratinocyte cancers in Australia.
Pandeya N; Olsen CM; Whiteman DC
Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
[TBL] [Abstract][Full Text] [Related]
11. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC
Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736
[TBL] [Abstract][Full Text] [Related]
12. Acitretin for Secondary Prevention of Keratinocyte Cancers in a Veteran Population: A Retrospective Cohort Study.
Lim RK; Weinstock MA; Landow SM
J Drugs Dermatol; 2021 Feb; 20(2):225-226. PubMed ID: 33538562
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma, not basal cell carcinoma, is the most common cancer in humans.
Brand D; Ackerman AB
J Am Acad Dermatol; 2000 Mar; 42(3):523-6. PubMed ID: 10688733
[No Abstract] [Full Text] [Related]
14. Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype.
Small J; Barton V; Peterson B; Alberg AJ
Adv Cancer Res; 2016; 130():257-91. PubMed ID: 27037755
[TBL] [Abstract][Full Text] [Related]
15. Viruses in Skin Cancer (VIRUSCAN): Study Design and Baseline Characteristics of a Prospective Clinic-Based Cohort Study.
Amorrortu RP; Fenske NA; Cherpelis BS; Vijayan L; Zhao Y; Balliu J; Messina JL; Sondak VK; Giuliano AR; Waterboer T; Pawlita M; Gheit T; Tommasino M; Rollison DE
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):39-48. PubMed ID: 31427307
[TBL] [Abstract][Full Text] [Related]
16. Keratinocyte alterations in skin tumour development.
Leigh IM; Purkis PE; Markey A; Collins P; Neill S; Proby C; Glover M; Lane EB
Recent Results Cancer Res; 1993; 128():179-91. PubMed ID: 7689238
[No Abstract] [Full Text] [Related]
17. [Clinico-epidemiologic survey of 3070 patients with cutaneous basal cell and squamous cell neoplasms].
Conte A; Lospalluti M; Meneghini CL
G Ital Dermatol Venereol; 1982; 117(2):67-72. PubMed ID: 7187384
[No Abstract] [Full Text] [Related]
18. Cohort studies (and skin cancer) never come alone.
Verkouteren JAC; van der Leest RJT; Nijsten T
J Invest Dermatol; 2015 Mar; 135(3):649-651. PubMed ID: 25666670
[TBL] [Abstract][Full Text] [Related]
19. Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus.
Hausauer AK; Maurer T; Leslie KS; Parvataneni R; Stuart SE; Chren MM
JAMA Dermatol; 2013 Feb; 149(2):239-41. PubMed ID: 23426494
[No Abstract] [Full Text] [Related]
20. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
